Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human Cancers.
Yang L, Tu W, Leng L, Huang L, Jiang W, Wang M, Wang Y, Meagher JL, Chinnaswamy K, Stuckey JA, Wang M, Wen B, Sun D, Harikrishnan L, Strickland C, Rice C, Orth P, Sui Z, Wang S.
Yang L, et al. Among authors: huang l.
J Med Chem. 2025 Jan 2. doi: 10.1021/acs.jmedchem.4c01904. Online ahead of print.
J Med Chem. 2025.
PMID: 39745073